Research
Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic
Danuta M. Skowronski, Travis S. Hottes, Naveed Z. Janjua, Dale Purych, Suzana Sabaiduc, Tracy Chan, Gaston De Serres, Jennifer Gardy, Janet E. McElhaney, David M. Patrick and Martin Petric
CMAJ November 23, 2010 182 (17) 1851-1856; DOI: https://doi.org/10.1503/cmaj.100910
Danuta M. Skowronski
Travis S. Hottes
Naveed Z. Janjua
Dale Purych
Suzana Sabaiduc
Tracy Chan
Gaston De Serres
Jennifer Gardy
Janet E. McElhaney
David M. Patrick
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic
Danuta M. Skowronski, Travis S. Hottes, Naveed Z. Janjua, Dale Purych, Suzana Sabaiduc, Tracy Chan, Gaston De Serres, Jennifer Gardy, Janet E. McElhaney, David M. Patrick, Martin Petric
CMAJ Nov 2010, 182 (17) 1851-1856; DOI: 10.1503/cmaj.100910
Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic
Danuta M. Skowronski, Travis S. Hottes, Naveed Z. Janjua, Dale Purych, Suzana Sabaiduc, Tracy Chan, Gaston De Serres, Jennifer Gardy, Janet E. McElhaney, David M. Patrick, Martin Petric
CMAJ Nov 2010, 182 (17) 1851-1856; DOI: 10.1503/cmaj.100910
Jump to section
Related Articles
Cited By...
- Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
- Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
- Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022
- Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020
- Detecting Signals of Seasonal Influenza Severity through Age Dynamics
- Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories
- High Incidence of Severe Influenza among Individuals over 50 Years of Age